Hyaluronic Acid Injection for Knee Arthritis
A hyaluronic acid injection for knee arthritis—also called a gel injection or viscosupplementation—is intended to alter the joint-fluid environment temporarily. It does not insert new cartilage or create a permanent cushion. Average study results are modest and inconsistent, so major guidelines do not recommend routine use.
Quick Answer
Hyaluronic acid does not regrow cartilage or cure osteoarthritis.
NICE advises not offering intra-articular hyaluronan for osteoarthritis.
AAOS does not recommend routine use for symptomatic knee osteoarthritis.
ACR conditionally recommends against its use in knee osteoarthritis.
Some clinicians still discuss it selectively after transparent counselling about uncertainty, cost and alternatives.
What Is Hyaluronic Acid?
Hyaluronic acid is a component of normal synovial fluid. Commercial products differ in molecular weight, cross-linking, manufacturing method, dose and number of injections. Results from one preparation cannot automatically be applied to every product.
Why Is It Called a Gel Injection?
“Gel injection” is a patient-friendly term. It can be misleading when it suggests that a new mechanical layer is inserted between the bones. The material is an injectable preparation intended to influence joint-fluid properties for a limited period.
What the Guideline Disagreement Means
NICE concluded that evidence did not show meaningful improvement in pain, function or quality of life and advises against offering hyaluronan. AAOS and ACR also advise against routine use, although their recommendation methods differ. These positions do not prove that no individual ever reports benefit; they mean average evidence is not strong or consistent enough for indiscriminate treatment.
Why It May Still Be Discussed Selectively
Some patients with confirmed mild or moderate knee osteoarthritis may ask about the option after exercise, topical treatment and suitable medicines have not provided enough relief or are unsuitable. A discussion should include the possibility of no response, direct cost, alternative injections and the risk of delaying a more appropriate plan. Selective discussion is not the same as guideline endorsement.
Who Is Less Likely to Benefit?
Advanced bone-on-bone arthritis with major deformity.
Severe loss of movement or substantial instability.
Pain mainly arising from the hip, spine, nerves or another diagnosis.
A large hot inflammatory effusion or suspected infection.
Previous failure of a correctly placed hyaluronic acid injection.
How the Procedure Is Performed
The diagnosis and recent weight-bearing imaging are reviewed when needed.
Medical conditions, medicines, allergies and previous injections are documented.
The skin is examined and cleaned using sterile technique.
Excess joint fluid may be aspirated when clinically indicated.
The identified product is injected into the joint.
Activity advice and warning signs are explained.
Single Injection or a Series?
Some preparations use one injection; others use a short series. More injections do not automatically mean better results. Before starting, the patient should know the exact product, number of visits, total cost and rationale.
When Might Benefit Appear?
When benefit occurs, it may develop gradually rather than immediately. The magnitude and duration vary and should not be promised. Walking, stairs, sleep and participation in exercise are more useful outcome measures than a vague impression of reduced pain.
Possible Risks
Temporary pain, stiffness or swelling.
Bruising or local discomfort.
An inflammatory reaction to the preparation.
Rare joint infection.
No meaningful improvement despite correct treatment.
Comparison With Cortisone
Corticosteroid injection is generally selected for faster short-term anti-inflammatory relief. Hyaluronic acid is not a steroid and has a slower, less predictable symptomatic effect. The choice should be based on the clinical problem—not a claim that one injection is universally safer or superior.
Read Cortisone Injection for Knee Arthritis.
Comparison With PRP and GFC
PRP and GFC are blood-derived preparations and have different processing, evidence and cost. None should be presented as guaranteed cartilage regeneration. Guideline positions on platelet-based injections also differ.
Read PRP Injection and GFC Therapy vs PRP.
Using Any Relief With Rehabilitation
If symptoms improve, the useful window should support strengthening, walking and activity progression. The injection does not correct weakness, balance problems or poor movement control.
Cost and Value
Value depends on probability, magnitude and duration of benefit, number of visits and alternatives. A premium brand or higher price does not guarantee a superior response. Product identity and full cost should be stated before treatment.
What to Do After an Unsuccessful Injection
Failure should prompt reassessment of diagnosis, injection placement, arthritis severity and other pain sources. Automatically switching brands or repeating a series may add cost without addressing the problem. Updated standing X-rays, hip or spine examination, or a revised rehabilitation plan may be more useful.
When to Move Beyond Injections
Reassess when injections provide no meaningful benefit, relief becomes progressively shorter, walking and sleep remain severely affected or deformity advances.
Read When Knee Injections Stop Working.
Questions Patients Commonly Ask
Is hyaluronic acid the same as a gel injection?
Yes. Gel injection is a common term for viscosupplementation.
Can it rebuild cartilage?
No. It should not be promoted as cartilage regeneration.
How many injections are needed?
The schedule depends on the product. Some use one injection and others use a series.
Is it safer than cortisone?
The risk profile is different rather than universally safer. Hyaluronic acid can cause local inflammatory reactions and may provide no meaningful benefit.
Why do guidelines recommend against it?
Because average evidence has not consistently demonstrated clinically important benefit sufficient for routine use.
Warning Signs After Injection
A hot, red, rapidly swollen knee, fever, severe worsening pain or inability to bear weight requires urgent assessment rather than home treatment as a routine injection reaction.
Clinical References
NICE NG226: Osteoarthritis in over 16s—diagnosis and management
AAOS Clinical Practice Guideline: Management of Osteoarthritis of the Knee (Non-Arthroplasty)
American College of Rheumatology Osteoarthritis Guideline
About Dr. Mayur Rabhadiya
Dr. Mayur Rabhadiya is an Orthopedic and Joint Replacement Surgeon in Mumbai. Qualifications: MBBS, D’Ortho, DNB (Orthopedics), MNAMS (Orthopedics), FIJR (Robotic & Navigation). Read his professional profile.
Book a Consultation
Consultations are available in Ghatkopar East and Ghatkopar West, Mumbai. Call or WhatsApp +91 84249 03913 or +91 96113 30063, or use the appointment page.
Medical Author and Reviewer
Written and medically reviewed by Dr. Mayur Rabhadiya, MBBS, D’Ortho, DNB (Orthopedics), MNAMS (Orthopedics), FIJR (Robotic & Navigation). Last medically reviewed: 17 July 2026.
Medical Disclaimer
This guide provides general education and does not replace individual examination, injection consent or treatment advice.